Astaxanthin Market Report and Forecast 2025-2034
Description
The global astaxanthin market size attained a value of USD 1.50 Billion in 2024. The market is likely to grow at a CAGR of 14.60% during the forecast period of 2025-2034, likely to reach a value of USD 5.86 Billion by 2034.
Global Market Likely to be Driven by Uses in Pharmaceuticals and Nutraceuticals
The nutraceutical market for encapsulated products has witnessed a surge due to the unique antioxidant properties of astaxanthin. It has been reported that astaxanthin offers several beneficial health effects and helps in the prevention and treatment of multiple diseases, including cancer, chronic inflammatory diseases, metabolic syndrome, diabetes, diabetic nephropathy, cardiovascular diseases, gastrointestinal diseases, liver diseases, neurodegenerative diseases, eye diseases, skin diseases, exercise-induced fatigue, male infertility, and renal failure. It is also said to boost immunity.
Astaxanthin, a xanthophyll carotenoid, is a dark-red, fat-soluble pigment that does not exhibit a pro-Vitamin A activity in human body (although it has been reported that astaxanthin carries more potent biological activity as compared to other carotenoids); it is the chief carotenoid found in algae and aquatic animals. Astaxanthin is found in several kinds of seafood, such as salmon, trout, red sea bream, shrimp and lobster; it is also found in birds like flamingo and quail. While synthetic astaxanthin is readily available in markets across the world, interest in natural sources of astaxanthin has grown significantly. Sources of natural astaxanthin include the green algae haematococcus pluvialis, the red yeast, Phaffia rhodozyma, and crustacean by-products. Haematococcus pluvialis, a green microalga gathers high astaxanthin matter under stress environments like high salinity, deficiency of nitrogen, high heat and light. Astaxanthin for human consumption is largely produced from H. pluvialis.
Health Benefits Offered by Astaxanthin and its Potential Use in Treatment of Various Diseases Expected to Boost the Global Astaxanthin Market
Astaxanthin’s antioxidant properties form the basis of reported health benefits. Astaxanthin has been associated with enhanced blood flow and reduced oxidative stress in smokers and obese individuals. According to some reports, comparative studies on astaxanthin and other carotenoids have revealed that astaxanthin exhibited the highest antioxidant activity against free radicals.
Astaxanthin has been reported to offer short- and long-term benefits for breast cancer treatment, including decreased growth of breast cancer cells.
Topical application of astaxanthin (in combination with oral dosage) is said to help in smoothing wrinkles, making age spots smaller, and maintaining skin moisture.
Some reports suggest that astaxanthin may help overcome fatigue after exercise and enhance endurance; it may also help prevent skeletal and muscle damage.
It has been suggested that astaxanthin may offer benefits related to heart health; it may prevent heart health and help decrease cholesterol levels.
Astaxanthin is also reported to show promise in treatment of conditions associated with joints, such as rheumatoid arthritis and carpal tunnel syndrome; astaxanthin may help decrease pain and inflammation in arthritis related symptoms.
Increasing Use of Astaxanthin in Food and Health Supplements Expected to Stimulate Global Astaxanthin Market
Astaxanthin is increasingly being used as a nutritional supplement in foods, feeds, pharmaceuticals and nutraceuticals. These applications are expected to contribute to market growth. For commercial applications, astaxanthin products generally come in the form of soft gels, capsules, oils, syrups, creams, tablets, biomass and granulated powders.
Market Segmentation
The EMR’s report titled “Astaxanthin Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
Global Market Likely to be Driven by Uses in Pharmaceuticals and Nutraceuticals
The nutraceutical market for encapsulated products has witnessed a surge due to the unique antioxidant properties of astaxanthin. It has been reported that astaxanthin offers several beneficial health effects and helps in the prevention and treatment of multiple diseases, including cancer, chronic inflammatory diseases, metabolic syndrome, diabetes, diabetic nephropathy, cardiovascular diseases, gastrointestinal diseases, liver diseases, neurodegenerative diseases, eye diseases, skin diseases, exercise-induced fatigue, male infertility, and renal failure. It is also said to boost immunity.
Astaxanthin, a xanthophyll carotenoid, is a dark-red, fat-soluble pigment that does not exhibit a pro-Vitamin A activity in human body (although it has been reported that astaxanthin carries more potent biological activity as compared to other carotenoids); it is the chief carotenoid found in algae and aquatic animals. Astaxanthin is found in several kinds of seafood, such as salmon, trout, red sea bream, shrimp and lobster; it is also found in birds like flamingo and quail. While synthetic astaxanthin is readily available in markets across the world, interest in natural sources of astaxanthin has grown significantly. Sources of natural astaxanthin include the green algae haematococcus pluvialis, the red yeast, Phaffia rhodozyma, and crustacean by-products. Haematococcus pluvialis, a green microalga gathers high astaxanthin matter under stress environments like high salinity, deficiency of nitrogen, high heat and light. Astaxanthin for human consumption is largely produced from H. pluvialis.
Health Benefits Offered by Astaxanthin and its Potential Use in Treatment of Various Diseases Expected to Boost the Global Astaxanthin Market
Astaxanthin’s antioxidant properties form the basis of reported health benefits. Astaxanthin has been associated with enhanced blood flow and reduced oxidative stress in smokers and obese individuals. According to some reports, comparative studies on astaxanthin and other carotenoids have revealed that astaxanthin exhibited the highest antioxidant activity against free radicals.
Astaxanthin has been reported to offer short- and long-term benefits for breast cancer treatment, including decreased growth of breast cancer cells.
Topical application of astaxanthin (in combination with oral dosage) is said to help in smoothing wrinkles, making age spots smaller, and maintaining skin moisture.
Some reports suggest that astaxanthin may help overcome fatigue after exercise and enhance endurance; it may also help prevent skeletal and muscle damage.
It has been suggested that astaxanthin may offer benefits related to heart health; it may prevent heart health and help decrease cholesterol levels.
Astaxanthin is also reported to show promise in treatment of conditions associated with joints, such as rheumatoid arthritis and carpal tunnel syndrome; astaxanthin may help decrease pain and inflammation in arthritis related symptoms.
Increasing Use of Astaxanthin in Food and Health Supplements Expected to Stimulate Global Astaxanthin Market
Astaxanthin is increasingly being used as a nutritional supplement in foods, feeds, pharmaceuticals and nutraceuticals. These applications are expected to contribute to market growth. For commercial applications, astaxanthin products generally come in the form of soft gels, capsules, oils, syrups, creams, tablets, biomass and granulated powders.
Market Segmentation
The EMR’s report titled “Astaxanthin Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Dried Algae Meal or Biomass
- Oil
- Softgel
- Liquid
- Others
- Natural
- Synthetic
- Aquaculture and Animal Feed
- Nutraceuticals
- Cosmetics
- Food and Beverages
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Algatech Ltd.
- Cyanotech Corporation
- Fuji Chemical Industries Co., Ltd.
- CO2 GRO Inc.
- MicroA
- E.I.D. – Parry (India) Limited
- Beijing Gingko Group
- Others
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Astaxanthin Market Overview
- 3.1 Global Astaxanthin Market Historical Value (2018-2024)
- 3.2 Global Astaxanthin Market Forecast Value (2025-2034)
- 4 Global Astaxanthin Market Landscape
- 4.1 Global Astaxanthin Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Astaxanthin Product Landscape
- 4.2.1 Analysis by Product Type
- 4.2.2 Analysis by Source
- 4.2.3 Analysis by Applications
- 5 Global Astaxanthin Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Astaxanthin Market Segmentation
- 6.1 Global Astaxanthin Market by Product
- 6.1.1 Market Overview
- 6.1.2 Dried Algae Meal or Biomass
- 6.1.3 Oil
- 6.1.4 Soft gel
- 6.1.5 Liquid
- 6.1.6 Others
- 6.2 Global Astaxanthin Market by Source
- 6.2.1 Market Overview
- 6.2.2 Natural
- 6.2.2.1 Yeast
- 6.2.2.2 Krill/Shrimp
- 6.2.2.3 Microalgae
- 6.2.2.4 Others
- 6.2.3 Synthetic
- 6.3 Global Astaxanthin Market by Application
- 6.3.1 Market Overview
- 6.3.2 Aquaculture and animal feed
- 6.3.3 Nutraceuticals
- 6.3.4 Cosmetics
- 6.3.5 Food and Beverages
- 6.3.6 Others
- 6.4 Global Astaxanthin Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Astaxanthin Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Astaxanthin Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Astaxanthin Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Astaxanthin Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Astaxanthin Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Clinical Trials Analysis
- 14.1 Analysis by Trial Registration Year
- 14.2 Analysis by Trial Status
- 14.3 Analysis by Trial Phase
- 14.4 Analysis by Therapeutic Area
- 14.5 Analysis by Geography
- 15 Funding Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Regulatory Framework
- 17.1 Regulatory Overview
- 17.1.1 US FDA
- 17.1.2 EU EMA
- 17.1.3 INDIA CDSCO
- 17.1.4 JAPAN PMDA
- 17.1.5 Others
- 18 Supplier Landscape
- 18.1 Algatech Ltd
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 Cyanotech Corporation.
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 MicroA
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Beijing Gingko Group (BGG)
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Algalíf Iceland ehf
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Fuji Chemical Industries Co., Ltd.
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 CO2 GRO Inc.
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 E.I.D. – Parry (India) Limited
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 PIVEG, Inc.
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Atacama Bio Natural Products S.A
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 18.11 ENEOS Corporation
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Mergers and Acquisitions
- 18.11.5 Certifications
- 19 Global Astaxanthin Market- Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 21 Company Competitiveness Analysis (Additional Insight)
- 21.1 Very Small Companies
- 21.2 Small Companies
- 21.3 Mid-Sized Companies
- 21.4 Large Companies
- 21.5 Very Large Companies
- 22 Payment Methods (Additional Insight)
- 22.1 Government Funded
- 22.2 Private Insurance
- 22.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
